TGTX logo

TGTX
TG Therapeutics Inc

21,285
Mkt Cap
$4.84B
Volume
3.26M
52W High
$46.48
52W Low
$25.28
PE Ratio
10.25
TGTX Fundamentals
Price
$28.50
Prev Close
$30.50
Open
$30.70
50D MA
$31.35
Beta
1.14
Avg. Volume
1.43M
EPS (Annual)
$0.1458
P/B
7.28
Rev/Employee
$973,384.61
Loading...
Loading...
News
all
press releases
TG Therapeutics (NASDAQ:TGTX) Stock Price Down 5.4% - Here's Why
TG Therapeutics (NASDAQ:TGTX) Shares Down 5.4% - Should You Sell...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Average Recommendation of "Moderate Buy" from Brokerages
Shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Get Free Report) have received a consensus rating of "Moderate Buy" from the five research firms that are currently covering the firm, Marketbeat...
MarketBeat·16d ago
News Placeholder
Osaic Holdings Inc. Sells 39,445 Shares of TG Therapeutics, Inc. $TGTX
Osaic Holdings Inc. cut its holdings in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 25.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·17d ago
News Placeholder
Is the Options Market Predicting a Spike in TG Therapeutics Stock?
Investors need to pay close attention to TGTX stock based on the movements in the options market lately.
Zacks·22d ago
News Placeholder
Marex Group plc Makes New $10.02 Million Investment in TG Therapeutics, Inc. $TGTX
Marex Group plc bought a new stake in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange...
MarketBeat·28d ago
News Placeholder
TG Therapeutics (NASDAQ:TGTX) Rating Increased to Buy at Wall Street Zen
Wall Street Zen raised shares of TG Therapeutics from a "hold" rating to a "buy" rating in a research report on Sunday...
MarketBeat·28d ago
News Placeholder
Eventide Asset Management LLC Increases Holdings in TG Therapeutics, Inc. $TGTX
Eventide Asset Management LLC lifted its holdings in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 32.8% in the second quarter, according to the company in its most recent 13F filing with the...
MarketBeat·29d ago
News Placeholder
Norges Bank Makes New Investment in TG Therapeutics, Inc. $TGTX
Norges Bank purchased a new stake in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange...
MarketBeat·1mo ago
News Placeholder
TG Therapeutics (NASDAQ:TGTX) Lowered to "Hold" Rating by Wall Street Zen
Wall Street Zen cut TG Therapeutics from a "buy" rating to a "hold" rating in a research report on Saturday...
MarketBeat·1mo ago
News Placeholder
Legal & General Group Plc Has $13.18 Million Stock Holdings in TG Therapeutics, Inc. $TGTX
Legal & General Group Plc trimmed its position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 3.9% during the 2nd quarter, according to its most recent Form 13F filing with the...
MarketBeat·1mo ago
<
1
2
...
>

Latest TGTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.